This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Jun 5;145(23):2676-2678.

doi: 10.1182/blood.2025028445.

Exploiting tumor-derived IL-10 activity in lymphoma therapy

Reuben Tooze¹, Ulf Klein¹

Affiliations

PMID: 40471622
DOI: 10.1182/blood.2025028445

Editorial

Exploiting tumor-derived IL-10 activity in lymphoma therapy

Reuben Tooze et al. Blood. 2025.

. 2025 Jun 5;145(23):2676-2678.

doi: 10.1182/blood.2025028445.

Authors

Reuben Tooze¹, Ulf Klein¹

Affiliation

¹ University of Leeds.

PMID: 40471622
DOI: 10.1182/blood.2025028445

No abstract available

PubMed Disclaimer

Comment on

IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy.
Garcia-Lacarte M, Grijalba SC, Melchor J, Pascual M, Goñi E, Clemente-Larramendi I, Morales-Sánchez S, Burrell MA, Blanco O, Arnaiz-Leché A, Berrozpe BS, Amann M, Klein C, Umaña P, Canales M, Martínez-Climent JÁ, Lasarte JJ, Sarobe P, Novo FJ, Roa S. Garcia-Lacarte M, et al. Blood. 2025 Jun 5;145(23):2746-2761. doi: 10.1182/blood.2024025755. Blood. 2025. PMID: 39899878

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems